Reports Q3 revenue ($7.676M), consensus $16.95M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WVE:
- Wave Life Sciences treatment of Huntington’s disease gets FDA orphan designation
- Wave Life Sciences Pte. Ltd (WVE) Q3 Earnings Cheat Sheet
- Wave Life Sciences price target raised to $22 from $19 at B. Riley
- Largest borrow rate increases among liquid names
- Wave Life Sciences Expands RNA Therapeutic Pipeline